Get the Stockscreener App
2.08
8.90%
0.17
After Hours:
2.07
-0.01
-0.48%
Io Biotech Inc stock is traded at $2.08, with a volume of 1.10M.
It is up +8.90% in the last 24 hours and up +58.78% over the past month.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
See More
Previous Close:
$1.91
Open:
$1.9
24h Volume:
1.10M
Relative Volume:
0.37
Market Cap:
$137.03M
Revenue:
-
Net Income/Loss:
$-86.08M
P/E Ratio:
-0.9641
EPS:
-2.1574
Net Cash Flow:
$-72.06M
1W Performance:
+6.67%
1M Performance:
+58.78%
6M Performance:
+128.57%
1Y Performance:
+170.87%
1-Day Range:
$1.90
$2.08
1-Week Range:
$1.71
$2.08
52-Week Range:
$0.66
$2.79
Io Biotech Inc Stock (IOBT) Company Profile
Name
Io Biotech Inc
Sector
Industry
Phone
(457) 070-2980
Address
OLE MAALOES VEH 3, COPENHAGEN
Compare IOBT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IOBT
Io Biotech Inc
|
2.08 | 116.61M | 0 | -86.08M | -72.06M | -2.1574 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Io Biotech Inc Stock (IOBT) Latest News
IO Biotech Inc. stock daily chart insights2025 Valuation Update & Precise Buy Zone Tips - Newser
Using flow based indicators on IO Biotech Inc.July 2025 Final Week & Weekly Top Performers Watchlists - Newser
Predicting IO Biotech Inc. trend using moving averages2025 Institutional Moves & Consistent Profit Trade Alerts - Newser
Does IO Biotech Inc. fit your quant trading modelMarket Trend Review & Precise Buy Zone Tips - Newser
What institutional flow reveals about IO Biotech Inc.July 2025 PreEarnings & Long Hold Capital Preservation Plans - Newser
What indicators show strength in IO Biotech Inc.July 2025 Fed Impact & Daily Stock Trend Reports - Newser
How to integrate IO Biotech Inc. into portfolio analysis toolsJuly 2025 Momentum & Fast Entry High Yield Stock Tips - Newser
How to track smart money flows in IO Biotech Inc.Trade Entry Report & Long-Term Investment Growth Plans - Newser
Combining machine learning predictions for IO Biotech Inc.Portfolio Update Summary & Proven Capital Preservation Methods - Newser
Why IO Biotech Inc. stock attracts strong analyst attentionEarnings Trend Report & AI Enhanced Trading Alerts - Newser
Relative strength of IO Biotech Inc. in sector analysis - Newser
Applying sector rotation models to IO Biotech Inc.Insider Selling & Expert-Curated Trade Recommendations - Newser
Should you hold or exit IO Biotech Inc. nowMarket Trend Summary & Risk Managed Trade Strategies - Newser
Pattern recognition hints at IO Biotech Inc. upsidePortfolio Value Summary & Growth Oriented Trade Recommendations - Newser
Using data filters to optimize entry into IO Biotech Inc.Entry Point & Safe Entry Momentum Tips - Newser
TD Cowen Maintains IO Biotech(IOBT.US) With Buy Rating - 富途牛牛
Analyzing IO Biotech Inc. with risk reward ratio chartsWeekly Stock Recap & Detailed Earnings Play Alerts - Newser
Can machine learning forecast IO Biotech Inc. recovery2025 Trading Volume Trends & Safe Entry Trade Reports - Newser
Fibonacci Retracement Aligns with Support in IO Biotech Inc.Buy Signal & Weekly Hot Stock Watchlists - beatles.ru
What to do if you’re stuck in IO Biotech Inc.Market Performance Report & Long-Term Capital Growth Strategies - Newser
News impact scoring models applied to IO Biotech Inc.Weekly Earnings Recap & Verified Short-Term Plans - Newser
Analyzing net buyer seller activity in IO Biotech Inc.Weekly Trading Summary & Verified Momentum Stock Watchlist - Newser
Short interest data insights for IO Biotech Inc.Market Movement Recap & AI Forecasted Entry and Exit Points - Newser
What data driven models say about IO Biotech Inc.’s futureEarnings Miss & Expert Verified Movement Alerts - Newser
Is Now a Good Time to Reenter IO Biotech Inc.Earnings Performance Report & AI Enhanced Trading Signals - beatles.ru
Is IO Biotech Inc. forming bullish engulfing patternsJuly 2025 Pullbacks & Low Risk Entry Point Guides - 뉴스영
Building trade automation scripts for IO Biotech Inc.2025 Market WrapUp & Weekly Chart Analysis and Guides - Newser
Will IO Biotech Inc. stock hit new highs in YEARDividend Hike & AI Powered Market Trend Analysis - خودرو بانک
IO Biotech says cancer vaccine with Merck’s Keytruda outperformed in late-stage study - MSN
IO Biotech’s vaccine misses on mPFS in phase III advanced melanoma trial - The Cancer Letter
What earnings revisions data tells us about IO Biotech Inc.Quarterly Portfolio Report & Long-Term Safe Return Strategies - Newser
Is IO Biotech Inc. a top pick in the sectorTrade Entry Summary & Daily Profit Maximizing Trade Tips - خودرو بانک
Io Biotech Inc Stock (IOBT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):